Thomas Theriault
Oprichter bij Bullet Biotechnology, Inc.
Actieve functies van Thomas Theriault
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Bullet Biotechnology, Inc.
 Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Hoofd Techniek/Wetenschap/O&O | 01-09-2011 | - |
| Oprichter | 01-09-2011 | - |
Loopbaan van Thomas Theriault
Eerdere bekende functies van Thomas Theriault
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GENITOPE CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-02-2005 | 31-03-2008 |
| INCYTE CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-08-1996 | 01-04-2004 |
Combion, Inc.
 Combion, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Combion, Inc. is a company that develops ink-jet technology for a variety of high-density gridding synthesis applications. The company is based in Pasadena, CA. The company was founded by Thomas Theriault, John D. Baldeschwieler. Combion was acquired by Incyte Corp. on August 15, 1996 for $2.98 million. | Hoofd Techniek/Wetenschap/O&O | 01-01-1996 | 01-01-1996 |
| Oprichter | 01-01-1996 | 01-01-1996 |
Opleiding van Thomas Theriault
| Dartmouth College | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Genitope Corp.
 Genitope Corp. BiotechnologyHealth Technology Genitope Corp. operates as a biotechnology company, which focuses on the research and development of novel immunotherapies for the treatment of cancer. The company was founded on August 15, 1996 and is headquartered in Redwood, CA. | Health Technology |
Combion, Inc.
Combion, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Combion, Inc. is a company that develops ink-jet technology for a variety of high-density gridding synthesis applications. The company is based in Pasadena, CA. The company was founded by Thomas Theriault, John D. Baldeschwieler. Combion was acquired by Incyte Corp. on August 15, 1996 for $2.98 million. | Commercial Services |
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Health Technology |
- Beurs
- Insiders
- Thomas Theriault
- Ervaring
